FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Natco Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524816 P/E (TTM) :10.36
ISIN Demat:INE987B01026 Div & Yield %:0.68 EPS (TTM) :84.75
Book Value (RS) :461.79599 Market Cap (Rs Cr.):15731.22 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Sep 2025)		 Quarter Ended
(Sep 2024)		 Quarter Ended
(% Var)
Sales 1,264.30 1,292.60 -2.19
Other Income 93.30 51.40 81.52
PBIDT 645.80 842.10 -23.31
Interest 11.70 3.00 290.00
PBDT 634.10 839.10 -24.43
Depreciation 48.10 42.20 13.98
PBT 586.00 796.90 -26.47
Tax 130.60 147.80 -11.64
Deferred Tax -45.50 -12.00 0.00
PAT 500.90 661.10 -24.23

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)